Late acute thrombosis after paclitaxel eluting stent implantation

Heart. 2001 Sep;86(3):262-4. doi: 10.1136/heart.86.3.262.

Abstract

Late (more than six months) total occlusion after coronary stenting is a progressive phenomenon occurring in approximately 4% of patients, leading to acute myocardial infarction in less than 0.5%. The process must be related to severe and progressive intimal hyperplasia. In patients receiving coronary stenting with simultaneous brachytherapy, late total occlusion has been reported at a higher rate and to be related to stent thrombosis rather than intimal hyperplasia. Late total occlusion presenting with an acute clinical event seven months after the implantation of a paclitaxel drug eluting stent is reported. The occlusion developed soon after the interruption of ticlopidine treatment, suggesting that the event had a thrombotic genesis and that the risk is not confined to the first six month period.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Angiogenesis Inhibitors / administration & dosage*
  • Aspirin / therapeutic use
  • Coronary Disease / drug therapy*
  • Coronary Thrombosis / etiology
  • Drug Implants
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy*
  • Paclitaxel / administration & dosage*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Recurrence
  • Risk Factors
  • Stents*
  • Ticlopidine / therapeutic use
  • Time Factors

Substances

  • Angiogenesis Inhibitors
  • Drug Implants
  • Platelet Aggregation Inhibitors
  • Ticlopidine
  • Paclitaxel
  • Aspirin